Why Blood Cancer?

Since 2000, more than 40% of cancer-fighting therapies approved by the FDA were first approved to treat blood cancer patients and many of these therapies are now helping patients with non-blood cancers. Some of the approved therapies are chemotherapy, bone and stem cell transplantation, and more recently immunotherapy.

Blood Cancer Statistics

An estimated 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2021. Within the last ten years, blood cancer survival rates have doubled, tripled, or quadrupled depending on the specific cancer. An estimated 1,361,567 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.

Climb

Event Day: Sunday March 26, 2023

General Registration: September 29th, 2022 at 9:00 AM

There is a fundraising minimum of $150/person ($100/person for those 17 and under) to benefit the Leukemia & Lymphoma Society's mission to eradicate blood cancers. Please note: All participants must reach the fundraising minimum to climb on event day.

Volunteer

If you are interested in volunteering for the event, please contact our interim Campaign Development Director, Jacquelyn Harvey, at jacquelyn.harvey@lls.org or 206.957.4574.